0001127602-16-041958.txt : 20160217 0001127602-16-041958.hdr.sgml : 20160217 20160217180004 ACCESSION NUMBER: 0001127602-16-041958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160212 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DiPietro Kenneth CENTRAL INDEX KEY: 0001540188 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 161435357 MAIL ADDRESS: STREET 1: C/O BIOGEN IDEC INC. STREET 2: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-02-12 0000875045 BIOGEN INC. BIIB 0001540188 DiPietro Kenneth BIOGEN INC. 225 BINNEY STREET CAMBRIDGE MA 02142 1 EVP Human Resources Common Stock 2016-02-12 4 M 0 1070 0 A 2724 D Common Stock 2016-02-12 4 F 0 504 247.22 D 2220 D Common Stock 2016-02-12 4 M 0 2246 0 A 4466 D Common Stock 2016-02-12 4 F 0 865 247.22 D 3601 D Restricted Stock Unit 0 2016-02-12 4 M 0 1070 0 D 2017-02-12 Common Stock 1070 3912 D Restricted Stock Unit 0 2016-02-12 4 M 0 2246 0 D 2017-02-12 Common Stock 2246 2249 D Restricted Stock Unit 0 2016-02-12 4 J 0 1418 0 D 2017-02-12 Common Stock 1418 2494 D The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]). This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. /s/ Matthew S. Gilman, Attorney in Fact for Kenneth DiPietro 2016-02-17